Possibly the greatest interest in the therapeutic potential of ghrelin concerns its use for the treatment of obesity and metabolic syndrome, given its well-established role in stimulating appetite and inducing adiposity [9,247]. Here, GHRL is linked to obesity due to melanocortin 4 receptor deficiency.